<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26208724</article-id>
      <article-id pub-id-type="pmc">4514988</article-id>
      <article-id pub-id-type="publisher-id">349</article-id>
      <article-id pub-id-type="doi">10.1186/s13000-015-0349-2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Epithelioid Rhabdomyosarcoma; a case report with immunohistochemical and molecular study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Jokoji</surname>
            <given-names>Ryu</given-names>
          </name>
          <address>
            <phone>+81-6-6543-3581</phone>
            <email>r.jokoji@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ikeda</surname>
            <given-names>Jun-ichiro</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tsujimoto</surname>
            <given-names>Masahiko</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Morii</surname>
            <given-names>Eiichi</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Pathology, Nissay Hospital, 6-3-8 Itachibori, Nishi-ku, Osaka, 550-0012 Japan </aff>
        <aff id="Aff2"><label/>Department of Pathology, Osaka Police Hospital, Osaka, Japan </aff>
        <aff id="Aff3"><label/>Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>25</day>
        <month>7</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>10</volume>
      <elocation-id>124</elocation-id>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>6</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>9</day>
          <month>7</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Jokoji et al. 2015</copyright-statement>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Recently, we encountered a biopsy of epithelioid rabdomyosarcoma with lymph node metastasis. A computed tomography (CT) scan showed number of swollen lymph nodes in the left neck and a huge abdominal mass occupying the right kidney. In the lymph node biopsy, tumor cells showed diffuse sheet-like growth reminiscent of carcinoma and melanoma cells with extensive distribution of coagulation necrosis. Tumor cells had abundant amphophilic cytoplasm and clear large nuclei. Most tumor cells showed severe cytologic atypia manifested in prominent nucleoli and pleomorphic nuclei. Tumor cells were focally positive for desmin. Most tumor cells showed expressons for vimentin, BAF47 (INI-1), and myogenin. On reverse transcriptase polymerase chain reaction (RT-PCR) analysis, tumor cells lacked Myo D1 and PAX3/7-FKHR transcripts and showed myogenin transcripts. On cytogenetic (karyotypic) analysis, tumor cells showed highly complex karyotypes. The patient received various regimens of chemotherapy, but 6&#xA0;months after the biopsy she died with progression of the tumor. Since consent was not obtained, an autopsy was not performed.</p>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s13000-015-0349-2) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Rhabdomyosarcoma</kwd>
        <kwd>Adult</kwd>
        <kwd>RT-PCR</kwd>
        <kwd>Immunohistochemistry</kwd>
        <kwd>Karyotype</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Rhabdomyosarcoma(RMS) is classified by the current World Health Organization (WHO) into four major subtypes, embryonal RMS (ERMS), alveolar RMS (ARMS), pleomorphic RMS (PRMS), and spindle cell/sclerosing RMS (SRMS) [<xref ref-type="bibr" rid="CR1">1</xref>]. Recently, a part of RMS demonstrated epithelioid morphorogy reminiscent of poorly differentiated carcinoma or melanoma and caused difficulty in diagnosis. Previous reports had identified these cases as epithelioid RMS (epiRMS) [<xref ref-type="bibr" rid="CR2">2</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>Clinical images: Computed tomography (CT), obtained before the biopsy, showing the swollen lymph nodes in the left neck (<bold>a</bold>, <italic>white arrow head</italic>) and a huge abdominal mass occupying the right kidney (<bold>b</bold>, <italic>white arrow head</italic>) as low-density masses</p></caption><graphic xlink:href="13000_2015_349_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Microscopic images: (<bold>a</bold>) Tumor cells showing diffuse sheet-like growth with extensive distribution of coagulation necrosis. <bold>b</bold> Tumor cells with abundant amphophilic cytoplasm and clear large nucleus with severe cytological atypia in the form of prominent nucleoli and pleomorphic nuclei</p></caption><graphic xlink:href="13000_2015_349_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Immunohistochemical images: Tumor cells stained weakly positive for vimentin (<bold>a</bold>) and negative for cytokeratin (<bold>b</bold>). Tumor cells stained focally positive for desmin (<bold>c</bold>) and diffusely positive for myogenin (<bold>d</bold>)</p></caption><graphic xlink:href="13000_2015_349_Fig3_HTML" id="MO3"/></fig></p>
      <p>We encountered a case of epiRMS with nodal metastasis, for which an extensive immunohistochemical and molecular study was performed.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 65-year-old female patient visited our clinic, complaining of low back pain, general fatigue and cervical masses. Computed tomography (CT) detected number of swollen lymph nodes in the left neck and a huge abdominal mass occupying the right kidney. Tumor growth had spread to retroperitoneal, regional and para aortic lymph nodes, and the aorta. CT showed no finding that tumor had been originated from a large nerve (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). There was no significant difference in the CT value between abdominal primary tumor and metastatic cervical lymph nodes (70&#x2013;90 Huns Hounsfield Unit (HU) and 60&#x2013;90 HU). Both lesions were suggested to be constructed from substantially the same components. For histological diagnosis, cervical lymph node biopsy was performed.</p>
      <p>Microscopically, tumor cells showed diffuse sheet-like growth reminiscent of carcinoma and melanoma cells with extensive distribution of coagulation necrosis. Tumor cells had abundant amphophilic cytoplasm and a clear large nucleus. Most tumor cells showed severe cytologic atypia manifested in the form of prominent nucleoli and pleomorphic nuclei. Tumor cells with bizarre nucleus were not found. No cross striations were observed (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). </p>
      <p>Immunohistochemistry for cytokeratin, LCA, S-100, Sox10, Melan A, smooth muscle actin, h-Caldesmon, MDM2, CDK4, p16 and Myo D1 was negative for all tumor cells. Tumor cells were focally positive for desmin. Most tumor cell showed weak expression for vimentin and diffuse expression for BAF47(INI-1), and myogenin (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). </p>
      <p>On reverse transcriptase polymerase chain reaction (RT-PCR) analysis, tumor cells lacked Myo D1, PAX3/7-FKHR transcripts and showed myogenin transcripts. On cytogenetic (karyotypic) analysis, tumor cells showed highly complex karyotypes with triploidy and structural rearrangements (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figures S1-3 and Tables S1-3).</p>
      <p>The final diagnosis was metastatic rhabdomyosarcoma with epithelioid morphology that originated from the right kidney or retroperitoneum. From morphological, immunohistochemical, cytogenetical and molecular analyses, we diagnosed the tumor to be a epiRMS. The patient received various regimen of chemotherapy, but 6&#x2005;months after the biopsy she died with progression of the tumor. Since consent was not obtained, an autopsy was not performed.</p>
    </sec>
    <sec id="Sec3" sec-type="conclusions">
      <title>Conclusion</title>
      <p>Epithelioid RMS was recently reported as a distinct morphological variant of RMS.</p>
      <p>RMS is classified by the current WHO into four major subtypes, ERMS, ARMS, PRMS, and SRMS. In previous reports with regard to other types of RMS, ERMS was characterized by primitive mesenchymal cells showing various stage of myogenesis and exhibited complex karyotypes with numerical and structural rearrangements, including polysomies of chromosomes 2, 8, 11, 12, and 13 [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. ARMS was typically characterized by primitive round cells surrounded by fibrovascular stroma and exhibited recurrent translocations, t(2; 13)(q35; q14)(PAX3-FKHR) and t(1; 13)(q35; q14)(PAX7-FKHR) in approximately 85% of cases. PAX3/7-FKHR fusion is specific to ARMS [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. PRMS was characterized by nuclear pleomorphism and bizarre polygonal eosinophilic cells and exhibited an extremely complex karyotype with numeric and structural rearrangements without specific genetic abnormality [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. SRMS was characterized by spindle cells and various degree of stromal hyalinization and exhibited aneuploidy without specific genetic abnormality in only few reports [<xref ref-type="bibr" rid="CR9">9</xref>&#x2013;<xref ref-type="bibr" rid="CR12">12</xref>].</p>
      <p>Histologically, epiRMS showed diffuse sheet-like growth of uniformly sized epithelioid cells with abundant amphophilic to eosinophilic cytoplasm, large vesicular nuclei, and frequent prominent nucleoli, reminiscent of poorly differentiated carcinoma or melanoma. Consequently, its morphology caused difficulty in diagnosis [<xref ref-type="bibr" rid="CR2">2</xref>]. Tumor cells showed skeletal muscle differentiation on immunohistochemical analysis, such as Myo D1 and/or myogenin. One of the differential diagnoses includes PRMS. However epiRMS lacks the obvious nuclear pleomorphism and bizarre polygonal eosinophilic cells that are characteristic of PRMS. Although most reports of epiRMS were of late elderly onset in the elderly, cases in children and young people have also been reported [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR13">13</xref>&#x2013;<xref ref-type="bibr" rid="CR18">18</xref>].</p>
      <p>In our case, the diagnosis of epiRMS was extremely difficult. The differential diagnosis for epiRMS includes poorly differentiated carcinoma, malignant melanoma, and epithelioid sarcoma. Morphologically, diffuse sheet-like growth pattern and severe cytologic atypia in the form of prominent nucleoli initially suggested carcinoma and melanoma cells. However, this was dismissed by immunohistochemical analysis that showed negative staining for cytokeratin, Melan A and S-100. Diffuse sheet-like epithelioid growth pattern with extensive distribution of necrosis and positive staining for vimentin suggested epithelioid sarcoma. However, this was rejected because immunohistochemistry showed positive staining for BAF47 (INI-1). In our case, since biopsy specimen only was evaluated, it might be part of tumor with rahbdomyosarcoma component, for example, dedifferentiated liposarcoma, Triton tumor, Rhabdoid tumor and carcinosarcoma. The differential diagnosis for dedifferentiated liposarcoma and Rhabdoid tumor were dismissed by immunohistochemical analysis that showed negative staining for MDM2, CDK4, p16 and positive staining for BAF47(INI1). The differential diagnosis for Triton tumor was dismissed by immunohistochemical analysis that showed negative staining for Sox10, S-100 and findings of abdominal CT. PRMS-like morphology, a sheets of large and atypical polygonal eosinophilic cells or of undifferentiated round to spindle cells with various degree of cross-striation, is more seen as a heterologous component in carcinosarcoma and dedeifferentiated liposarcoma, among others [<xref ref-type="bibr" rid="CR1">1</xref>]. Furthermore from findings of abdominal CT, it was unlikely that tumor had heterogeneous components.</p>
      <p>In our case, the expression of myogenin confirmed by immunohistochemistry and RT-PCR analysis led to the diagnosis of epiRMS. Twenty-four cases of epiRMS have been reported [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR13">13</xref>&#x2013;<xref ref-type="bibr" rid="CR18">18</xref>]. In most cases, tumor cells showed diffuse and strong positive staining for desmin, which would be suggested a myogenic tumor. In our case, tumor cells showed only focal positive staining for desmin, which made it difficult for a correct diagnosis.</p>
      <p>In our case, the PAX3/7-FKHR fusion genes were subjected to RT-PCR and karyotype-analysis.</p>
      <p>The PAX3/7-FKHR fusion gene is specific to ARMS. The presence of the fusion gene was not confirmed in our case as in past epiRMS cases [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. On cytogenetic (karyotypic) analysis, tumor cells showed highly complex karyotypes with triploidy and structural rearrangements. There was no description of cytogenetic analysis in the past epiRMS cases.</p>
      <p>As Jo et al. described, our case showed diffuse sheet-like growth with abundant amphophilic cytoplasm and a clear large nucleus in the deep soft tissues of elderly patient and exhibited an aggressive clinical course [<xref ref-type="bibr" rid="CR2">2</xref>]. The expression of myogenin confirmed by immunohistochemistry and RT-PCR analysis. In past cases, tumor cells showed diffuse and strong positive staining for desmin [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR13">13</xref>&#x2013;<xref ref-type="bibr" rid="CR18">18</xref>]. In our case, however, tumor cells showed focal positive staining for desmin and was not comfirmed the expression of desmin by RT-PCR analysis. The reason there is no expression of desmin is unclear.</p>
      <p>From the cytogenetical point of view, ARMS is an independent variant because of the recurrent translocations. ERMS, PRMS and SRMS exhibit complex karyotype with numeric and structural rearrangements. PRMS and SRMS occur mainly in elderly adults, while ERMS can also occur in elderly adults. Non-specific complex karyotypes with numeric and structural rearrangements may be common findings in adult RMS, apart from their morphological diversity. EpiRMS may also share a common finding in karyotypic analysis. Stock et al. argued that adult-type RMS is a single entity with wide morphological variety [<xref ref-type="bibr" rid="CR7">7</xref>]. EpiRMS may also be one of the morphological diverse types in adult-type RMS.</p>
      <p>In conclusion, a case of epiRMS occurring in an adult is reported. The differential diagnosis for epiRMS includes poorly differentiated carcinoma, malignant melanoma, and epithelioid sarcoma. It is difficult to distinguish epiRMS only by morphological analysis from other tumors that showed epithelioid morphology. Immunohistochemical and/or molecular analyses are needed to make the correct diagnosis. It is not clear whether epiRMS is an independent entity in RMS. Although it is difficult to properly treat adult RMS including epiRMS because of the aggressive clinical course, the correct diagnosis is needed for the discovery and improvement of future therapy. A larger-scale, multi-institute study is needed to provide more insight into epiRMS.</p>
    </sec>
    <sec id="Sec4">
      <title>Consent</title>
      <p>Written informed consent was obtained from the next of kin of the patient for publication of this Case Report and any accompanying images.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec5">
          <title>Additional file</title>
          <p>
            <media position="anchor" xlink:href="13000_2015_349_MOESM1_ESM.zip" id="MOESM1">
              <label>Additional file 1: Figure S1.</label>
              <caption>
                <p>RT-PCR analysis. <bold>Figure S2.</bold> Karyotypic analysis of tumor cells. <bold>Figure S3.</bold> Additional immunohistochemical images. <bold>Table S1.</bold> Details of used antibodies. <bold>Table S2.</bold> The details of karyotype. <bold>Table S3.</bold> Primer sequences for the detection of Myo D1, Myogenin and PAX3/7-FKHR fusion gene.</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>RMS</term>
          <def>
            <p>Rhabdomyosarcoma</p>
          </def>
        </def-item>
        <def-item>
          <term>WHO</term>
          <def>
            <p>World Health Organization</p>
          </def>
        </def-item>
        <def-item>
          <term>ERMS</term>
          <def>
            <p>Embryonal rhabdomyosarcoma</p>
          </def>
        </def-item>
        <def-item>
          <term>ARMS</term>
          <def>
            <p>Alveolar rhabdomyosarcoma</p>
          </def>
        </def-item>
        <def-item>
          <term>PRMS</term>
          <def>
            <p>Pleomorphic rhabdomyosarcoma</p>
          </def>
        </def-item>
        <def-item>
          <term>SRMS</term>
          <def>
            <p>Spindle cell/sclerosing rhabdomyosarcoma</p>
          </def>
        </def-item>
        <def-item>
          <term>epiRMS</term>
          <def>
            <p>Epithelioid rhabdomyosarcoma</p>
          </def>
        </def-item>
        <def-item>
          <term>CT</term>
          <def>
            <p>Computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>HU</term>
          <def>
            <p>Huns Hounsfield unit</p>
          </def>
        </def-item>
        <def-item>
          <term>RT-PCR</term>
          <def>
            <p>Reverse transcriptase polymerase chain reaction</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>JI, MT participated in the concept of the case report, interpreted the H&amp;E slides and immunochemical, molecular and karyotypic studies; RJ was responsible for the interpreting H&amp;E slides and immunochemical, molecular and karyotypic studies, review of the literature, writing the manuscript and processing digital images; EM was responsible for writing the manuscript and conclusions. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgment</title>
      <p>The authors thank Mr. Masaharu Kohara, Department of Pathology, Osaka University Graduate School of Medicine, for technical assistance.</p>
      <p>This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan (#T264604700).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Fletcher</surname>
              <given-names>CDM</given-names>
            </name>
            <name>
              <surname>Bridge</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Hogendoorn</surname>
              <given-names>PCW</given-names>
            </name>
            <name>
              <surname>Mertens</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <source>WHO classification of tumours of soft tissue and bone</source>
          <year>2013</year>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jo</surname>
              <given-names>VY</given-names>
            </name>
            <name>
              <surname>Marino-Enriquez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fletcher</surname>
              <given-names>CD</given-names>
            </name>
          </person-group>
          <article-title>Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma</article-title>
          <source>Am J Surg Pathol</source>
          <year>2011</year>
          <volume>35</volume>
          <issue>10</issue>
          <fpage>1523</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1097/PAS.0b013e31822e0907</pub-id>
          <pub-id pub-id-type="pmid">21921782</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gordon</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>McManus</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Min</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Swansbury</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pritchard-Jones</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study</article-title>
          <source>Med Pediatr Oncol</source>
          <year>2001</year>
          <volume>36</volume>
          <issue>2</issue>
          <fpage>259</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.1002/1096-911X(20010201)36:2&lt;259::AID-MPO1063&gt;3.0.CO;2-K</pub-id>
          <pub-id pub-id-type="pmid">11452933</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weber-Hall</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McManus</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nojima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Pinkerton</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization</article-title>
          <source>Cancer Res</source>
          <year>1996</year>
          <volume>56</volume>
          <issue>14</issue>
          <fpage>3220</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">8764111</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gallego Melcon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sanchez de Toledo Codina</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Molecular biology of rhabdomyosarcoma</article-title>
          <source>Clin Transl Oncol</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>415</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1007/s12094-007-0079-3</pub-id>
          <pub-id pub-id-type="pmid">17652054</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sorensen</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Lynch</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Qualman</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Tirabosco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Maurer</surname>
              <given-names>HM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children&#x2019;s oncology group</article-title>
          <source>J Clin Oncol</source>
          <year>2002</year>
          <volume>20</volume>
          <issue>11</issue>
          <fpage>2672</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2002.03.137</pub-id>
          <pub-id pub-id-type="pmid">12039929</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stock</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Chibon</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Binh</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Terrier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Michels</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Valo</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis</article-title>
          <source>Am J Surg Pathol</source>
          <year>2009</year>
          <volume>33</volume>
          <issue>12</issue>
          <fpage>1850</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1097/PAS.0b013e3181be6209</pub-id>
          <pub-id pub-id-type="pmid">19898221</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ogose</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kawashima</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Umezu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hotta</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tohyama</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cytogenetic and real-time quantitative reverse-transcriptase polymerase chain reaction analyses in pleomorphic rhabdomyosarcoma</article-title>
          <source>Cancer Genet Cytogenet</source>
          <year>2009</year>
          <volume>1</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chiles</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Parham</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Qualman</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Teot</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Bridge</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Ullrich</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sclerosing rhabdomyosarcomas in children and adolescents: a clinicopathologic review of 13 cases from the Intergroup Rhabdomyosarcoma Study Group and Children&#x2019;s Oncology Group</article-title>
          <source>Pediatr Dev Pathol</source>
          <year>2004</year>
          <volume>7</volume>
          <issue>6</issue>
          <fpage>583</fpage>
          <lpage>94</lpage>
          <pub-id pub-id-type="doi">10.1007/s10024-004-5058-x</pub-id>
          <pub-id pub-id-type="pmid">15630526</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Croes</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Debiec-Rychter</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cokelaere</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>De Vos</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hagemeijer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sciot</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Adult sclerosing rhabdomyosarcoma: cytogenetic link with embryonal rhabdomyosarcoma</article-title>
          <source>Virchows Arch</source>
          <year>2005</year>
          <volume>446</volume>
          <issue>1</issue>
          <fpage>64</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1007/s00428-004-1131-0</pub-id>
          <pub-id pub-id-type="pmid">15660283</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuhnen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Herter</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Leuschner</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Mentzel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Druecke</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jaworska</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sclerosing pseudovascular rhabdomyosarcoma-immunohistochemical, ultrastructural, and genetic findings indicating a distinct subtype of rhabdomyosarcoma</article-title>
          <source>Virchows Arch</source>
          <year>2006</year>
          <volume>449</volume>
          <issue>5</issue>
          <fpage>572</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1007/s00428-006-0282-6</pub-id>
          <pub-id pub-id-type="pmid">17016719</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bouron-Dal Soglio</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rougemont</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Absi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Barrette</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Montpetit</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fetni</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>SNP genotyping of a sclerosing rhabdomyosarcoma: reveals highly aneuploid profile and a specific MDM2/HMGA2 amplification</article-title>
          <source>Hum Pathol</source>
          <year>2009</year>
          <volume>9</volume>
          <fpage>1347</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2009.01.021</pub-id>
          <pub-id pub-id-type="pmid">19454362</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suarez-Vilela</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Izquierdo-Garcia</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Alonso-Orcajo</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Epithelioid and rhabdoid rhabdomyosarcoma in an adult patient: a diagnostic pitfall</article-title>
          <source>Virchows Arch</source>
          <year>2004</year>
          <volume>445</volume>
          <issue>3</issue>
          <fpage>323</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1007/s00428-004-1076-3</pub-id>
          <pub-id pub-id-type="pmid">15517372</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bertorelle</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dall&#x2019;Igna</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Manzitti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gambini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bisogno</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study</article-title>
          <source>Am J Surg Pathol</source>
          <year>2014</year>
          <volume>38</volume>
          <issue>2</issue>
          <fpage>273</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1097/PAS.0000000000000105</pub-id>
          <pub-id pub-id-type="pmid">24418861</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feasel</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Marburger</surname>
              <given-names>TB</given-names>
            </name>
            <name>
              <surname>Billings</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Primary cutaneous epithelioid rhabdomyosarcoma: a rare, recently described entity with review of the literature</article-title>
          <source>J Cutan Pathol</source>
          <year>2014</year>
          <pub-id pub-id-type="pmid">24628673</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bowe</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Ozer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bridge</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Iwenofu</surname>
              <given-names>OH</given-names>
            </name>
          </person-group>
          <article-title>Primary intranodal epithelioid rhabdomyosarcoma</article-title>
          <source>Am J Clin Pathol</source>
          <year>2011</year>
          <volume>136</volume>
          <issue>4</issue>
          <fpage>587</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1309/AJCPRQES4NFDQ0XC</pub-id>
          <pub-id pub-id-type="pmid">21917681</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fujiwaki</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Miura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Endo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yoshino</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Iwanari</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Sawada</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Primary rhabdomyosarcoma with an epithelioid appearance of the fallopian tube: an adult case</article-title>
          <source>Eur J Obstet Gynecol Reprod Biol</source>
          <year>2008</year>
          <volume>2</volume>
          <fpage>289</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejogrb.2008.02.016</pub-id>
          <pub-id pub-id-type="pmid">18395958</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seidal</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kindblom</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Angervall</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Rhabdomyosarcoma in middle-aged and elderly individuals</article-title>
          <source>APMIS</source>
          <year>1989</year>
          <volume>97</volume>
          <issue>3</issue>
          <fpage>236</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1699-0463.1989.tb00783.x</pub-id>
          <pub-id pub-id-type="pmid">2713135</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
